Article: Brentuximab vedotin associated with durable remissions and long-term survival in patients with relapsed/ refractory Hodgkins’ lymphoma

€3.03

SKU: product-article-17991 Category: General

Description
Reviews (0)

Description

Brentuximab vedotin associated with durable remissions and long-term survival in patients with relapsed/ refractory Hodgkins’ lymphoma

Reviews

There are no reviews yet.

Be the first to review “Article: Brentuximab vedotin associated with durable remissions and long-term survival in patients with relapsed/ refractory Hodgkins’ lymphoma”

You must be logged in to post a review.

Top

Article: Brentuximab vedotin associated with durable remissions and long-term survival in patients with relapsed/ refractory Hodgkins’ lymphoma

Description

Reviews

Related products

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in urologic cancer

Article: INTRODUCTION